• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume9, Issue7

Effect of Corporate Governance Disclosure on Financial Performance of BSE Listed Companies

    Akansha Singhal Dr. Om Prakash Agrawal

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 5293-5300

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The sole purpose of this study is to examine the impact of corporate governance disclosure on the financial performance of companies listed in BSE. Disclosure of corporate affairs is very important the interest groups of the companies and it effect the financial performance of the companies. Financial performance can be measured through the various financial ratios such as liquidity ratio, profitability ratio and solvency ratio. For the investigating impact of corporate governance disclosure on financial performance we have collected secondary data from the official websites. Data of three years of 10 companies listed in BSE have been collected. Various statistical tools with the help of E-views have been applied to do investigation. Finding of the study indicated that corporate governance disclosure significantly influences financial performance.
Keywords:
    BSE Financial Performance corporate governance Disclosure
  • PDF (429 K)
  • XML
(2022). Effect of Corporate Governance Disclosure on Financial Performance of BSE Listed Companies. European Journal of Molecular & Clinical Medicine, 9(7), 5293-5300.
Akansha Singhal; Dr. Om Prakash Agrawal. "Effect of Corporate Governance Disclosure on Financial Performance of BSE Listed Companies". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 5293-5300.
(2022). 'Effect of Corporate Governance Disclosure on Financial Performance of BSE Listed Companies', European Journal of Molecular & Clinical Medicine, 9(7), pp. 5293-5300.
Effect of Corporate Governance Disclosure on Financial Performance of BSE Listed Companies. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 5293-5300.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 37
  • PDF Download: 45
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus